PRESCRIBING · PART D · 2024
Total Rx claims
26
Beneficiaries
—
Total drug cost
$355K
Distinct drugs
2
Brand share
57.7%
Top prescribed drugs
Fedratinib Dihydrochloride15 claims
Hydroxyurea11 claims
QUALITY · MIPS · 2024
Final MIPS score
93.8
Quality
74.6
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.79%
APM Entity
CROSS-REFERENCE